Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Glycopyrronium + Indacaterol, ATC R03AL12 für die Zeit 01.01.2027 - 31.12.2028
Conclusion of a non-exclusive discount agreement according to § 130a para 8 SGB V on the active substance glycopyrronium + indacaterol, ATC R03AL12 for the period 01.01.2027 - 31.12.2028English, machine translated
Issued by DAK-Gesundheit · via Bekanntmachungsservice — Germany (federal notices)
- Published
- 17 Nov 2026
- Closes
- 5 Nov 2028, 11:00 UTC
- Reference
- 1005552- Glycopyrronium + Indacaterol,(z) ATC R03AL12
- Location
- DE, Germany
- Sector
- Healthcare & Pharma
- Type
- goods
At a glance
DAK-Gesundheit in Germany has published a tender in healthcare & pharma: “Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Glycopyrronium + Indacaterol, ATC R03AL12 für die Zeit 01.01.2027 - 31.12.2028”. Submissions close on 5 November 2028, 718 days from today. Quote reference 1005552- Glycopyrronium + Indacaterol,(z) ATC R03AL12 in any correspondence with the buyer. FreeTender has recorded 92 notices from this buyer since 2026, 74 of them currently open. There are 883 open healthcare & pharma notices in Germany on FreeTender. Bids are submitted to the buyer through Bekanntmachungsservice — Germany (federal notices), not through FreeTender.
Key requirements
Taken from the notice by FreeTender. The tender document on the official portal is binding — check it, and any corrigendum, before you bid.
To bid on EU public procurement
Most EU buyers ask for the European Single Procurement Document (ESPD) as a self-declaration with the bid. Submission is on the e-procurement platform named in the notice.
English summary
Machine translated from German by FreeTender. The original notice below is the binding text.
Contracting authority: DAK-Health. Lot: LOT-0001 CPV code: 33600000. Place of performance: DE. Published: 17 November 2026. Deadline for receipt of tenders: 05 November 2028 12:00. Published on the German federal notice service (announcement service, oeffentlichevergabe.de); the full notice and documents are on the source page.
Details
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Glycopyrronium + Indacaterol, ATC R03AL12 für die Zeit 01.01.2027 - 31.12.2028
Contracting authority: DAK-Gesundheit.
Lot: LOT-0001.
CPV code: 33600000.
Place of performance: DE.
Published: 17 November 2026.
Deadline for receipt of tenders: 05 November 2028 12:00.
Published on the German federal notice service (Bekanntmachungsservice, oeffentlichevergabe.de); the full notice and documents are on the source page.
Context for bidders
We hold 92 notices from DAK-Gesundheit, going back to August 2026 — 74 of them still open. They buy mostly in Healthcare & Pharma, IT & Telecom and Financial & Professional Services. There are 883 open Healthcare & Pharma tenders in Germany. This one closes in 718 days.
More from this buyer
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Morphin (ausschl. in der Dafo. FTA + HKP + SMT), ATC N02AA01 f. d. Z. 01.01.27-31.12.28, zzgl V.-Option 1x12M· closes 5 Nov
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Mometason (ausschl. in der Dafo. Lösung), ATC D07AC13 f. d. Z. 01.01.2027-31.12.2028 (zzgl. V.-Option 1x12 M)· closes 5 Nov
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Pamidronsäure, ATC M05BA03 für die Zeit 01.01.2027 - 31.12.2028 (zzgl. V.-Option 1x12 Monate)· closes 5 Nov
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Clindamycin + Benzoylperoxid, ATC D10AF54 für die Zeit 01.01.2027 - 31.12.2028 (zzgl. V.-Option 1x12 Monate)· closes 5 Nov
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Sevelamer hydrochlorid, ATC V03AE02 für die Zeit 01.01.2027 - 31.12.2028 (zzgl. V.-Option 1x12 Monate)· closes 5 Nov
Similar Healthcare & Pharma tenders
- Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026-24 - Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml)· closes 31 Dec
- Open House Biologika Rabattverträge 2026-24 - Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml)· closes 31 Dec
- Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 12 Epoetin alfa und Epoetin zeta· closes 31 Dec
- Open-House-Biologika-Rabattverträge 2026-05 - Pegfilgrastim· closes 30 Apr
- Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2026-05 - Pegfilgrastim· closes 30 Apr
Explore Germany
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
Who won similar contracts
Recent contract awards in Germany, from published award notices.
- Suivi et Contrôle des travaux d'alimentation en eau potable d'Issia et localités environnantesWon by GOPA - International Energy Consultants GmbH (Allemagne) · XOF 151,478,080.00 · 30 Sept 2026
- Supervision of works for Viroi bridgeWon by Schneider & Partner Ingenieur-consult GMBH (Germany) · EUR 140,000.00 · 18 Aug 2026
More Healthcare & Pharma tenders
- Поставка лекарственных препаратов для медицинского применения (КЕТОРОЛАК)ДЕПАРТАМЕНТ КОНТРАКТНОЙ СИСТЕМЫ КУЗБАССА · Russia
- Поставка лекарственных препаратов для медицинского применения (МАГНИЯ СУЛЬФАТ)ДЕПАРТАМЕНТ КОНТРАКТНОЙ СИСТЕМЫ КУЗБАССА · Russia
- Оказание услуг по проведению лабораторных исследований с целью осуществления производственного контроля в Филиале «Отделение в городе Нефтеюганске» на 2027 и 2028 годаКАЗЕННОЕ УЧРЕЖДЕНИЕ ХАНТЫ-МАНСИЙСКОГО АВТОНОМНОГО ОКРУГА - ЮГРЫ "БЮРО СУДЕБНО-МЕДИЦИНСКОЙ ЭКСПЕРТИЗЫ" · Russia
- Поставка медицинских изделий: Рулон марлевый тканыйГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ "ЦЕНТРАЛЬНАЯ РАЙОННАЯ БОЛЬНИЦА АПШЕРОНСКОГО РАЙОНА" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ КРАСНОДАРСКОГО КРАЯ · Russia
- Оказание услуг по проведению лабораторных исследований с целью осуществления производственного контроля в филиале «Отделение в городе Югорске» на 2027 и 2028 годаКАЗЕННОЕ УЧРЕЖДЕНИЕ ХАНТЫ-МАНСИЙСКОГО АВТОНОМНОГО ОКРУГА - ЮГРЫ "БЮРО СУДЕБНО-МЕДИЦИНСКОЙ ЭКСПЕРТИЗЫ" · Russia
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →